期刊文献+

11-羟基甘草萜醇类化合物的制备及体外抗氧化活性研究

Preparation and in vitro Antioxidant Activity of 11-hydroxylic Glycyrrhetol Derivatives
下载PDF
导出
摘要 为提高甘草次酸(Ib)的抗氧化活性,对其化学结构进行修饰,制备11-羟基甘草萜醇类衍生物。各化合物的抗氧化活性由肝微粒体中的细胞色素P450/NADPH氧化系统做体外抗氧化实验模型进行测定。微粒体中的自由基由探针物DCFH-DA的氧化程度进行检测。维生素E作为阳性对照物。通过还原反应获得甘草萜醇类两种光学异构体———11α-羟基物(2)和11β-羟基物(3)。这两种化合物显示出较强的抗氧化活性,以1.0 mg/mL浓度,分别抑制自由基浓度为50%和51%。相同条件下,先导物Ib和维生素E分别抑制31%和32%的自由基活性。以上结果显示,对先导物Ib的C11位羰基和C30位羧基进行还原修饰,可显著提高其抗氧化活性,这种修饰将能增强先导物对自由基损伤有关病理性病变(如AS)的防治潜能。 Chemical modification was performed to glycyrrhetinic acid(Ib) for improving its antioxidant property. 11- Hydroxylic glycyrrhetol derivativestwo optical isomers-the compounds 2 and 3 were obtained by the reaction of reduction. Their in vitro antioxidant activities were studied using a cytochrome P450/NADPH reductase system from rat liver microsomes. The generation of microsomal free radicals was followed by oxidation of the DCFH-DA probe, while evaluating the capacity to inhibit reactive oxygen species (ROS) formation. The two optical isomers-compounds 2 and 3 exhibited strong antioxidant activities ,and at a concentration of 1.0 mg/mL,they inhibited ROS formation by 50% and 51% , respectively. In the same conditions, the lead compound (Ib) and the reference vitamin E inhibited ROS activity by 31% and 32%. Our results suggested that the chemical reduction of the 11 -keto and 30-carboxyl groups into hydroxyl function can increase the antioxidant activity and anti-atherosclerotic potency of Ib significantly.
出处 《天然产物研究与开发》 CAS CSCD 2008年第4期604-608,共5页 Natural Product Research and Development
基金 教育部重点项目(207128)
关键词 甘草次酸 结构修饰 11-羟基甘草萜醇类 抗氧化活性 glycyrrhetinic acid chemical modification 11-hydroxylic glycyrrhetol derivatives antioxidant activity
  • 相关文献

参考文献24

  • 1Shibata SA. Drug over the millennia : pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi, 2000, 120 : 849-862.
  • 2Inoue H,Nagata N, Shibata S, et al. Inhibitory effect of glycyrrhetinic acid derivatives on capsaicin-induced ear edema in mice. Jpn J Pharmacol , 1996,71:281-289.
  • 3Farina C, Pinza M, Pifferi G. Synthesis and anti-ulcer activity of new derivatives of glycyrrhetic: oleanolic and ursolic acids. Farmaco, 1998,53:22-32.
  • 4Arase Y, Ikeda K, Murashima N, et al. The long-term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer, 1997, 79 : 1494-500.
  • 5Villetinek AT, Debruyne T, Apers S, et al. Plant derived leading eompounds for ehemotherapy of human immunodeficiency virus infeetion. Planta Med, 1998,64:97-109.
  • 6Tanaka M. The effect of glycyrrhizin on carcinogenesis in the duodenum of mice N-ethyl-N-nitro-N-nitroso guanidine. Kyotofuritsu Ika Daigaku Zasshi , 1991,100 : 1139.
  • 7Zakirov UB, A bdullaev AK. The hypolipidemic and antiatherosclerotic properties of the ammonium salt of glycyrrhetic acid and of 18-dehydroglycyrrhetic acid. Eksp Klin Farmakol , 1996,59:53-55.
  • 8Hye GJ,Sung JP,Ae RM ,et al. Hepatoprotective effects 18β- glycyrrhefinie acid on carbon tetrachloride-indueed liver injury :inhibition of cytochrome P450 2El expression.Pharmacological Research, 2002,46 : 221-227.
  • 9Shibata S, Takahashi K, Yano S, et al. Chemical modificatior of glycyrrhetinic acid in relation to the biol0gical activities. Chem Pharm Bull( Tokyo), 1987,35 : 1910-1918.
  • 10Ablise M, Cartier A, Siest G, et al. Molecular pharmacophore determination of lipid lowering drugs with the receptor mapping method. Mini Rev Med Chem,2002,2 :97-102.

二级参考文献7

  • 1吴锡铭,吕坚,茹仁萍.甘草酸18H差向异构体的比较研究[J].中国药学杂志,1993,28(4):215-218. 被引量:22
  • 2[4]Ichikawa T, Ishida S, Sakiya Y, Sawasy Y, Hanano M. Biliary excretion and enterohepatic cycling of glycyrrhizin in rats[J]. J pharm Sci, 1986;75(7) :672- 5
  • 3[5]Wan Rossum TG, Vulto AG, De Man RA, Brouwen T Schalm SW. Review article: glycyrrhizin as a potential treatment for chronic hepatitis C[J]. Aliment Pharmacol Ther, 1998; 12(2):199 - 205
  • 4[6]Wang A, Nishioka M, Kurosaki Y, Nakayama T, Kimura T.Gastrointestinal absorption characteristics of glycyrrhizin from glycyrrhiza extract[J]. Biol Pharm Bull, 1995; 18(9): 1238 -41
  • 5[7]Amagaya S, Sugishita E, Ogihara Y, Ogawa S, Okada K,Aizawa T. Comparative studies of the stereolsomers of glycyrrhetinc acid on anti-inflammatory activities [J]. J Pharmacrobiodum, 1984;7(12):923 - 8
  • 6徐会选.甘草酸类药物的不良反应[J].药物不良反应杂志,2003,5(3):166-171. 被引量:47
  • 7吴锡铭,吕坚.甘草酸差向异构体对大鼠肝损害的治疗作用[J].中国药理学报,1992,13(4):370-374. 被引量:24

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部